Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections
Access

151 - 164 of 164 Items

Editorial2022, apr 29

Incidence and disease prevalence for lymphoid neoplasms in Poland

Krzysztof Giannopoulos

Vol 53, No 2 (2022)

Editorial

Acta Haematol Pol 2022;53(2):73-74.
Original research article2022, apr 13

Assessment of colonization and infection epidemiology in patients undergoing autologous hematopoietic stem cell transplantation: a single-center study

Kinga Michalina Krawiec, Magdalena Czemerska, Piotr Stelmach, Agnieszka Wierzbowska, Agnieszka Pluta

Vol 53, No 2 (2022)

Original research article

Acta Haematol Pol 2022;53(2):133-140.
Review article2022, apr 11

The diagnostic pitfalls and challenges associated with basic hematological tests

Aleksandra Kubiak, Ewelina Ziółkowska, Anna Korycka-Wołowiec

Vol 53, No 2 (2022)

Review article

Acta Haematol Pol 2022;53(2):104-111.
Review article2022, apr 6

Chronic lymphocytic leukemia following venetoclax treatment failure

Oktawia Sośnia, Bartosz Puła

Vol 53, No 2 (2022)

Review article

Acta Haematol Pol 2022;53(2):94-103.
Review article2022, apr 5

Chronic myeloid leukemia: where do we stand, where can we go?

Krzysztof Lewandowski, Jakub Lewandowski

Vol 53, No 3 (2022)

Review article

Acta Haematol Pol 2022;53(3):153-165.
Guidelines / Expert consensus2022, mar 7

Treatment recommendations developed by MDS experts of the Polish Adult Leukemia Group (PALG) for management of myelodysplastic syndromes (MDSs) and other MDS-related conditions in Poland for 2021

Krzysztof Mądry, Bożena Katarzyna Budziszewska, Karol Lis, Joanna Drozd-Sokołowska, Bartłomiej Pogłódek, Rafał Machowicz, Edyta Subocz, Katarzyna Wisniewska-Piąty, Tomasz Wróbel, Jan Maciej Zaucha, Ewa Zarzycka, Ewa Karakulska-Prystupiuk, Lidia Gil, Aleksandra Butrym, Agnieszka Tomaszewska, Grzegorz Władysław Basak, Anna Waszczuk-Gajda, Agnieszka Pluta, Paweł Szwedyk, Małgorzata Jarmuż-Szymczak, Jagoda Rytel, Jadwiga Dwilewicz-Trojaczek

Vol 53, No 2 (2022)

Guidelines / Expert consensus

Acta Haematol Pol 2022;53(2):75-93.
Short communication2022, feb 25

Ruxolitinib for steroid-refractory acute graft versus host disease: case series and literature review

Adrianna Spałek, Krzysztof Woźniczka, Anna Armatys, Agata Wieczorkiewicz-Kabut, Izabela Noster, Grzegorz Helbig

Vol 53, No 1 (2022)

Short communication

Acta Haematol Pol 2022;53(1):66-68.
Original research article2022, feb 25

Mean platelet volume and other hematological parameters in pediatric migraine

Yılmaz Akbaş

Vol 53, No 1 (2022)

Original research article

Acta Haematol Pol 2022;53(1):53-57.
Editorial2022, feb 25
Original research article2022, feb 25

Role of tumor necrosis factor-alpha–308 G/A and interleukin-10 promotor–592 C/A polymorphisms in adult immune thrombocytopenic purpura

Amani Fouad Sorour, Ahmed Mohamed Lotfy Bedewy, Irene Lewis Mikhael, Asmaa Ahmed Abd El-Aziz El-Zokm, Samar Mahmoud Masoud Aboelsaad, Salma Alaa Eldin Imbaby

Vol 53, No 1 (2022)

Original research article

Acta Haematol Pol 2022;53(1):58-65.
Clinical vignette2022, feb 23
Clinical vignette2022, feb 23

Class switch recombination defect in child with ataxia–telangiectasia with hyper IgM phenotype

Eman Gamal Baz, Mohamed Almalky, Tarek A. Abdelaziz

Vol 53, No 1 (2022)

Clinical vignette

Acta Haematol Pol 2022;53(1):69-71.
Original research article2022, feb 8

Chemotherapy delays in children with acute lymphoblastic leukemia might influence the outcome of treatment

Anna Puła, Maciej Zdunek, Kaja Michalczyk, Maciej Cichosz, Wojciech Młynarski

Vol 53, No 2 (2022)

Original research article

Acta Haematol Pol 2022;53(2):141-148.
Review article2022, jan 20

Modeling congenital dyserythropoietic anemia in genetically modified mice

Ranju Kumari, Piotr Kaźmierczak

Vol 53, No 1 (2022)

Review article

Acta Haematol Pol 2022;53(1):26-38.